Comparative Effectiveness of Ipsilesional High-frequency rTMS, Contralesional Continuous Burst Theta rTMS, and Sham rTMS, Each Combined With Physiotherapy, in Subacute Ischemic Stroke Upper Limb Recovery : Clinical, Neurophysiological and Radiological

NCT ID: NCT06799312

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-15

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the efficacy of lesional high-frequency rTMS, contralesional cTBS, and sham stimulation in improving motor and cognitive recovery in post-stroke patients undergoing physiotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Globally, stroke is the second leading cause of both death and disability. In 2020, the global prevalence of all stroke subtypes was 89.13 million cases, with acute ischemic stroke (AIS) comprising 76.47% of these, equating to 68.16 million cases . AIS presents a major global public health concern, given the wide range of disabilities it causes, including cognitive impairments. Survivors of stroke bear a significant burden due to the persistent disability they experience over time . Immediately following a stroke, motor impairments are accompanied by significant alterations in the affected primary motor cortex (M1) - detected by transcranial magnetic stimulation (TMS)- resulting in reduced cortical excitability. This can be evidenced by the absence of recordable motor evoked potentials (MEPs), diminished MEP amplitudes, and increased resting motor threshold (rMT). Additionally, stroke can alter brain connectivity, particularly in terms of functional connectivity, which has implications for recovery. Neuroplasticity plays a crucial role in recovery after stroke, allowing the brain to reorganize and compensate for lost functions. Physiotherapy is a cornerstone of post-stroke rehabilitation, particularly for upper limb recovery and cognitive improvement, with early intervention associated with better outcomes. Repetitive transcranial magnetic stimulation (rTMS) has shown promise in the early stages post-stroke, enhancing motor and cognitive recovery, particularly when applied within two weeks of stroke onset. MEPs can be used to monitor changes in cortical excitability and have been linked to both cognitive and motor recovery. Combining rTMS with diffusion tensor imaging (DTI) allows for the assessment of both functional and structural brain changes, providing a deeper understanding of rTMS's therapeutic effects. DTI, through fractional anisotropy (FA), helps to evaluate white matter integrity, and studies have shown that increased FA correlates with motor recovery, making it a valuable tool in examining the structural changes induced by rTMS in stroke recovery. While high frequency rTMS targeting the ipsilesional motor cortex (M1) has demonstrated efficacy in enhancing motor recovery, contralesional continuous theta-burst stimulation (cTBS) has shown promising results offering an alternative by modulating interhemispheric inhibition. However, no studies have directly compared the efficacy of these two paradigms against each other and sham stimulation in subacute stroke recovery. This study seeks to address this gap by comparing the outcomes of lesional high frequency rTMS, contralesional cTBS, and sham stimulation in combination with physiotherapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Repetitive Transcranial Magnetic Stimulation Stroke Functional MRI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A double blinded randomized controlled trial comparing different interventions on separate groups simultaneously.
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Both participants and investigators are blinded to the intervention type, with sham rTMS serving as the control for maintaining blinding integrity.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ipsilesional high frequency rTMS combined with physiotherapy

rTMS Protocol:

Stimulation delivered to the hand area of the ipsilesional primary motor cortex (M1).

Frequency: 3 Hz.

Stimulation: 2 seconds per train, 37 trains per session.

Total pulses: 750 per session at 130% of the resting motor threshold (RMT).

Physiotherapy:

Patients receive standard physiotherapy sessions.

Group Type ACTIVE_COMPARATOR

Ipsilesional high frequency rTMS combined with physiotherapy

Intervention Type DEVICE

As mentioned in details in arms description.

Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

rTMS Protocol:

Stimulation delivered to the contralesional primary motor cortex (M1).

Protocol: Continuous bursts of 3 stimuli at 50 Hz, repeated at 5 bursts per second.

Duration: 40 seconds per session.

Stimulation intensity: 70% of RMT with a biphasic TMS-induced current at a 45° angle to the midline.

Physiotherapy:

Patients receive standard physiotherapy sessions.

Group Type ACTIVE_COMPARATOR

Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

Intervention Type DEVICE

As mentioned in details in arms description.

Sham rTMS + Physiotherapy

Patients receive a sham stimulation designed to mimic rTMS without delivering active magnetic pulses.

This maintains blinding for participants and investigators.

Physiotherapy:

Patients receive standard physiotherapy sessions.

Group Type SHAM_COMPARATOR

Sham rTMS + Physiotherapy

Intervention Type DEVICE

As mentioned in details in arms description.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ipsilesional high frequency rTMS combined with physiotherapy

As mentioned in details in arms description.

Intervention Type DEVICE

Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

As mentioned in details in arms description.

Intervention Type DEVICE

Sham rTMS + Physiotherapy

As mentioned in details in arms description.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First-ever ischemic stroke, confirmed by imaging.
* Stroke affecting the non-dominant hemisphere (cortical or subcortical) within the middle cerebral artery (MCA) territory.
* Acute to subacute stage of stroke (time since onset: 48 hours to 2 weeks).
* Ability to comply with the study protocol and interventions.

Exclusion Criteria

* Hemorrhagic stroke or bilateral stroke.
* Severe cognitive impairment, defined as a Montreal Cognitive Assessment (MoCA) score \< 10.
* Contraindications to TMS, such as: History of epilepsy, Metallic implants in the head, Other contraindications based on TMS safety guidelines.
* Comorbid conditions that limit participation in rehabilitation.
* Severe neglect or aphasia that would impede participation in therapy.
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammad Ahmad Mohammad Korayem

Assisstant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohammad Ahmad Korayem, Assistant lecturer

Role: CONTACT

+201021478054

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NeuroRehabStroke2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.